HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Oxycodone Hydrochloride

HCID 5462350
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
124-90-3
Standard SMILES
COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.Cl
InChIKey
MUZQPDBAOYKNLO-RKXJKUSZSA-N
Molecular formula
C18H22ClNO4
Average molar mass
351.8 g/mol
Monoisotopic mass
351.1237359

Overview

Oxycodone hydrochloride is a hydrochloride obtained by reaction of oxycodone with one molar equivalent of hydrochloric acid. It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain. It has a role as an opioid analgesic, an antitussive and a mu-opioid receptor agonist. It contains an oxycodone(1+).

Names & identifiers

Preferred name
Oxycodone Hydrochloride
IUPAC
(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride

Names & synonyms

Oxycodone hydrochloride124-90-3Oxycodone HclOxectaEndocodoneRoxicodoneDihydrone hydrochlorideDihydrooxycodeinone hydrochlorideOxycodone hydrochloride ciiOxynormDihydroxycodeinone hydrochlorideROXYBOND
Show more names
C1ENJ2TE6C14-Hydroxydihydrocodeinone hydrochlorideANHYDROUS OXYCODONE HYDROCHLORIDE4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one hydrochlorideCHEBI:7859DTXSID80924674TARGINIQ COMPONENT OXYCODONE HYDROCHLORIDETROXYCA COMPONENT OXYCODONE HYDROCHLORIDE

Database identifiers

CAS
124-90-3
PubChem CID
5462350
DTXSID
DTXSID80924674
ChEMBL
CHEMBL1200890
ChEBI
CHEBI:7859
UNII
C1ENJ2TE6C
EC Number
204-717-1

Properties

Computed structural properties

Topological polar surface area
59 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
1
Heavy atoms
24
Formal charge
0
Complexity
553

Experimental & physicochemical properties

Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Analgesics, Opioid; Narcotics; Antitussive Agents; Opiates

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (95.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P317, P321, P330, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 64 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Other Safety InformationIMAP assessments - Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-,hydrochloride, (5.alpha.)-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (95.3%)

Toxicology

Treatment · 1 item

To treat Oxycodone overdose, primary attention should be given to the reestablishment of a patent airway and institution of assisted or controlled ventilation. Supportive measures (including oxygen and vasopressors) should be employed in the management of circulatory shock and pulmonary edema accompanying overdose as indicated. Cardiac arrest or arrhythmias may require cardiac massage or defibrillation. The narcotic antagonists, naloxone or nalmefene, are specific antidotes for opioid overdose. Opioid antagonists should not be administered in the absence of clinically significant respiratory or circulatory depression secondary to Oxycodone overdose. If needed the appropriate dose of naloxone hydrochloride or nalmefene should be administered simultaneously with efforts at respiratory resuscitation (see package insert for each drug for the details). Since the duration of action of oxycodone may exceed that of the antagonist, the patient should be kept under continued surveillance and repeated doses of the antagonist should be administered as needed to maintain adequate respiration. Gastric emptying may be useful in removing unabsorbed drug. (L1712)

Chemistry & industry

Pharmacology

Metabolism/MetabolitesHepatic Route of Elimination: Oxycodone and its metabolites are excreted primarily via the kidney. Half Life: 4.5 hours
FDA Pharmacological Classification · 6 items

OXYCODONE HCL

Opioid Agonist [EPC]; Full Opioid Agonists [MoA]

OXYCODONE HYDCHLORIDE

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

OXYCODONE HYDROCHLORIDE

Opioid Agonist [EPC]; Full Opioid Agonists [MoA]

MeSH Pharmacological Classification · 2 items

Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.

Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS.

Uses & manufacturing

UsesFor the treatment of diarrhoea, pulmonary oedema and for the relief of moderate to moderately severe pain.

Related reactions

56 records
New reaction record
HRID 68197 reaction equation
HRID 68197As reactant
HRID 84140 reaction equation
HRID 84140As product
HRID 84141 reaction equation
HRID 84141As product
HRID 84142 reaction equation
HRID 84142As product
HRID 219481 reaction equation
HRID 219481As reactant
HRID 254843 reaction equation
HRID 254843As product
HRID 333509 reaction equation
HRID 333509As reactant
HRID 403094 reaction equation
HRID 403094As reactant
PreviousPage 1 of 7

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Health EffectsMedical problems can include congested lungs, liver disease, tetanus, infection of the heart valves, skin abscesses, anemia and pneumonia. Death can occur from overdose.
Exposure RoutesOral; enteral (rectal). Well absorbed with an oral bioavailability of 60% to 87%
Toxicity Summary · 1 item

Oxycodone acts as a weak agonist at mu, kappa, and delta opioid receptors within the central nervous system (CNS). Oxycodone primarily affects mu-type opioid receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as oxycodone also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (kappa-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (mu and delta receptor agonist). This results in hyperpolarization and reduced neuronal excitability.

Signs and SymptomsSymptoms of overdose include respiratory depression, somnolence progressing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, constricted pupils, bradycardia, hypotension, and death.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Oxycodone hydrochloride

vLess-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation